UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021318
Receipt No. R000023942
Scientific Title Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus
Date of disclosure of the study information 2016/03/03
Last modified on 2019/03/19 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus
Acronym Study on antipruritic action of Neurotropin injection
Scientific Title Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus
Scientific Title:Acronym Study on antipruritic action of Neurotropin injection
Region
Japan

Condition
Condition dermal pruritus
Classification by specialty
Dermatology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Effect of Neurotropin injection for dermal pruritus
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Sift of Shiratori's grade in pruritus severity during 7 weeks' intervention
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus
Before a week, eight week treatment
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Pruritis patient
2)Over 20-years-old
3)treatment of pruritis over a week
4)pruritic grade 2>=
5)agreement for this study
6)possible writing of pruritic daily
Key exclusion criteria 1)allergy for Neurotropin
2)other effective drug treatment for pruritis
3)patient of feed, pregnancy, or possible of pregnancy
4)impossible regularly consultation
5)heavy disease of heart, liver, or kidney
6)ohter impossible patient
Target sample size 33

Research contact person
Last name of lead principal investigator
1st name Sakae
Middle name
Last name Kaneko
Organization Shimane University Hospital
Division name Dermatology
Zip code 6938501
Address Enya 89-1 Izumo Shimane 693-8501 Japan
TEL 0853-20-2210
Email kanekos2@med.shimane-u.ac.jp

Public contact
1st name of contact person
1st name Sakae
Middle name
Last name Kaneko
Organization Shimane University Hospital
Division name Dermatology
Zip code 6938501
Address Enya 89-1 Izumo Shimane 693-8501 Japan01, Japan
TEL 0853-20-2210
Homepage URL
Email kanekos2@med.shimane-u.ac.jp

Sponsor
Institute Department of Dermatology Faculty of Medicine Shimane University
Institute
Department

Funding Source
Organization Research center for prevention of lifestyle-related disease
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Dean of Faculty of Medicine, Shimane University
Address enya-cho 89-1, Izumo city
Tel 0853-20-2515
Email mga-kikaku@office.shimane-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 03 Day

Related information
URL releasing protocol https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Publication of results Published

Result
URL related to results and publications https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Number of participants that the trial has enrolled 40
Results
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Results date posted
2019 Year 03 Month 11 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Participant flow
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Adverse events
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Outcome measures
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12021
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 03 Month 03 Day
Date of IRB
2015 Year 12 Month 21 Day
Anticipated trial start date
2016 Year 03 Month 04 Day
Last follow-up date
2017 Year 12 Month 01 Day
Date of closure to data entry
2017 Year 12 Month 01 Day
Date trial data considered complete
2017 Year 12 Month 01 Day
Date analysis concluded
2017 Year 12 Month 01 Day

Other
Other related information

Management information
Registered date
2016 Year 03 Month 03 Day
Last modified on
2019 Year 03 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023942